Borax

Sodium Borate is a naturally occurring mineral and buffering agent used extensively in medical preparations, including ophthalmic solutions and allergenic extracts, to maintain pH stability and provide mild antiseptic properties.

Because Sodium Borate is primarily used as an excipient (an inactive ingredient that supports the active drug), there is no single 'standard dose' for the compound itself. Instead, the dosage is determined by the specific product in which it is contained.

• Ophthalmic Use: For eye washes or lubricating drops containing Sodium Borate, the typical instruction is 1 to 2 drops in the affected eye(s) as needed, or as directed by a physician. For eye irrigation, the volume used depends on the necessity of flushing debris or contaminants.
• Allergenic Extracts: When Sodium Borate is part of an allergenic extract (e.g., for food or pollen allergies), the dosage is highly individualized. It usually begins with a very low concentration (e.g., 0.05 mL of a 1:100,000 w/v dilution) and is gradually increased over several months during the 'build-up' phase of immunotherapy.
• Topical Application: For creams containing Sodium Borate, a thin layer is generally applied to the affected area 2-3 times daily. Patients should avoid applying these products to large areas of broken skin.

Pediatric use of Sodium Borate must be approached with extreme caution due to the higher risk of systemic toxicity in children relative to their body surface area.

• Infants: Use of Sodium Borate-containing products is generally discouraged in infants, especially for topical application on the diaper area, as absorption can lead to severe toxicity (historically known as 'borism').
• Children (2-12 years): Ophthalmic drops may be used under strict medical supervision. Dosage usually mirrors adult dosing but requires careful monitoring for any signs of irritation.
• Adolescents: Same as adult dosing for approved indications.

Renal Impairment

Since Sodium Borate is primarily excreted by the kidneys, patients with chronic kidney disease (CKD) or acute kidney injury (AKI) are at a significantly higher risk of boron accumulation. While topical or ophthalmic use rarely requires adjustment, systemic exposure (via large-scale topical application on damaged skin) should be avoided in this population. No specific GFR-based dosing scales exist, but clinical vigilance is required.

Hepatic Impairment

As Sodium Borate is not metabolized by the liver, no specific dosage adjustments are typically required for patients with liver disease. However, the overall health of the patient should be considered before starting any new medication.

Elderly Patients

Older adults often have age-related declines in renal function. Healthcare providers should use the lowest effective amount of Sodium Borate-containing products and monitor for signs of systemic absorption, such as gastrointestinal upset or skin changes.

• Ophthalmic Drops: Wash hands thoroughly. Tilt the head back, pull down the lower eyelid, and drop the solution into the pouch. Close the eye and apply gentle pressure to the corner of the eye (nasolacrimal duct) for 1 minute to minimize systemic absorption.
• Topical Creams: Apply only to intact skin. Do not use under occlusive dressings (airtight bandages) unless specifically instructed by a doctor, as this increases absorption.
• Storage: Store at room temperature (15°C to 30°C / 59°F to 86°F). Keep the container tightly closed and away from moisture. Keep out of reach of children, as ingestion can be fatal.

If you miss a dose of a product containing Sodium Borate, apply or use it as soon as you remember. If it is nearly time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose to catch up.

Sodium Borate overdose is a medical emergency. Signs of acute poisoning include:

• Severe vomiting and diarrhea (often blue-green in color).
• A bright red skin rash (described as 'boiled lobster' appearance), followed by skin peeling.
• CNS stimulation followed by depression (seizures, lethargy).
• Kidney failure (oliguria or anuria).

In case of accidental ingestion or excessive topical application, contact a Poison Control Center (1-800-222-1222 in the US) or seek emergency medical attention immediately.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or use the product for longer than prescribed without medical guidance.

When used as directed in ophthalmic or topical preparations, Sodium Borate is generally well-tolerated. However, some users may experience:

• Local Irritation: A mild stinging or burning sensation immediately following application to the eye or skin. This usually subsides within a few minutes.
• Mild Redness: Temporary hyperemia (increased blood flow) to the area of application.
• Watery Eyes: Increased lacrimation (tearing) after using ophthalmic drops.

• Contact Dermatitis: Some individuals may develop a localized allergic reaction, characterized by itching, small bumps, or a localized rash at the site of skin application.

Sodium Borate is intended for external use only. It should never be ingested. Even small amounts of boron compounds can be toxic to children and pets. Ensure all products containing this ingredient are stored in a secure location. If you are using a product for the eyes, ensure the tip of the dropper does not touch any surface, including the eye itself, to prevent contamination.

As of 2026, there are no specific FDA black box warnings for Sodium Borate as a chemical entity. However, as noted previously, it is a component in Non-Standardized Allergenic Extracts, which do carry a Black Box Warning. The warning states that these products can cause severe life-threatening systemic reactions, including anaphylaxis. These products should only be administered by physicians experienced in the treatment of allergic diseases and in facilities where emergency equipment is available.

• Broken Skin Risk

Sodium Borate is chemically incompatible with several substances, which can lead to the formation of precipitates or the neutralization of therapeutic effects:

• Alkaloids: Sodium Borate is alkaline and can cause the precipitation of alkaloidal salts (such as cocaine, morphine, or atropine) in solution. This renders the medication ineffective and potentially dangerous if the precipitate is injected or applied to the eye.
• Metallic Salts: It is incompatible with salts of mercury, silver, and lead. Combining these can result in toxic chemical reactions or loss of drug potency.

• Polyvinyl Alcohol (PVA): Sodium Borate reacts with PVA (found in some artificial tears) to form a thick, gel-like substance. While sometimes used intentionally in 'gel' drops, an unplanned interaction can cause significant eye discomfort and temporary vision blockage.

Sodium Borate must NEVER be used in the following circumstances:

1. 1Known Hypersensitivity: Any patient with a documented allergy to borax, boric acid, or any borate-containing compound should not use these products. An allergic reaction could range from localized dermatitis to systemic anaphylaxis.
2. 2Large Areas of Denuded Skin: It is strictly contraindicated for use on extensive areas of broken skin, such as major burns, severe eczema, or 'weeping' dermatitis. The risk of rapid systemic absorption leading to fatal kidney failure and CNS toxicity is unacceptably high.
3. 3Internal Use/Ingestion: Sodium Borate is not for internal consumption. Ingestion of as little as 5 to 10 grams in adults (and much less in children) can be fatal.
4. 4

Sodium Borate is generally classified as Pregnancy Category C (by the older FDA system). There is limited data on the use of Sodium Borate in pregnant women. Animal studies have shown that high doses of boron (administered orally) can cause developmental toxicity, including skeletal malformations and reduced fetal weight. While systemic absorption from ophthalmic or limited topical use is low, caution is advised. It is especially important to avoid application to the abdominal or breast area where the skin may be stretched or sensitive. During the first trimester, use should be strictly limited to essential cases.

It is not known whether Sodium Borate is excreted in human milk in significant quantities. However, boron is a natural trace element found in milk. The primary risk during breastfeeding is 'accidental ingestion' by the infant if the mother applies borate-containing creams to the nipple or breast area. If such products must be used, the area should be thoroughly cleaned before nursing. Most clinicians recommend safer alternatives for nursing mothers.

Children are significantly more susceptible to boron toxicity than adults. Their skin is thinner, and their surface-area-to-weight ratio is higher, leading to greater systemic absorption. Sodium Borate should never be used as a 'dusting powder' for children. In ophthalmic preparations, it is generally considered safe for children over the age of 2 when used for short durations under medical supervision. Growth effects have not been documented with topical use, but chronic systemic exposure can interfere with nutrient absorption.

Sodium Borate acts primarily as a chemical stabilizer and pH buffer. In aqueous solution, the tetraborate ion (B4O7^2-) reacts with water to form a mixture of boric acid [B(OH)3] and the borate anion [B(OH)4^-]. This conjugate acid-base pair creates a buffering system that maintains the solution's pH within a narrow range (typically 7.0 to 9.0).

At the cellular level, borates have a high affinity for cis-diol groups, which are found in many biologically important molecules like glycoproteins and RNA. By binding to these groups, borates can inhibit certain bacterial enzymes, providing the compound's mild antiseptic effect. In allergenic extracts, this binding helps stabilize the three-dimensional structure of proteins, preventing them from unfolding (denaturing).

• Onset of Action: For pH buffering and lubrication (ophthalmic), the effect is immediate upon application.
• Duration of Effect: The buffering effect lasts as long as the solution remains on the surface (e.g., 1-4 hours in the eye). Systemically, the effects of absorbed boron can last for several days due to its distribution into bone.